• 沒有找到結果。

SYNDROMES, DISORDERS AND MATERNAL RISK FACTORS ASSOCIATED WITH NEURAL TUBE DEFECTS (IV)

N/A
N/A
Protected

Academic year: 2022

Share "SYNDROMES, DISORDERS AND MATERNAL RISK FACTORS ASSOCIATED WITH NEURAL TUBE DEFECTS (IV)"

Copied!
3
0
0

加載中.... (立即查看全文)

全文

(1)

Author(s): Chen, CP (Chen, Chih-Ping)

Title: SYNDROMES, DISORDERS AND MATERNAL RISK FACTORS ASSOCIATED WITH NEURAL TUBE DEFECTS (IV)

Source: TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 47 (2): 141-150 JUN 2008

Language: English Document Type: Review

Author Keywords: fetal; maternal; neural tube defects; risk factors

KeyWords Plus: FOLIC-ACID FORTIFICATION; REDUCED FOLATE CARRIER;

DIHYDROFOLATE-REDUCTASE DHFR; IN-VITRO FERTILIZATION; THYMIDYLATE SYNTHASE GENE; DEHYDROGENASE-METHENYLTETRAHYDROFOLATE-

CYCLOHYDROLASE; PERICONCEPTIONAL VITAMIN SUPPLEMENTATION; SPINA- BIFIDA PREGNANCY; MAJOR BIRTH-DEFECTS; METHYLENETETRAHYDROFOLATE REDUCTASE

Abstract: Fetuses with neural tube defects (NTDs) may be associated with maternal and fetal risk factors. This article provides a comprehensive review of maternal and fetal risk factors associated with NTDs, such as infertility, periconceptional clomiphene use and assisted reproductive technology, periconceptional folic acid deficiency and effects of folic acid supplementation and fortification on NTD rates, periconceptional vitamin B12 deficiency, single nucleotide polymorphisms and polymorphisms in genes of folate metabolism, and maternal autoantibodies to folate receptors. NTDs associated with maternal and fetal risk factors are an important cause of NTDs. Perinatal identification of NTDs should alert the clinician to the maternal and fetal risk factors associated with NTDs, and prompt a thorough etiologic investigation and genetic counseling. [Taiwan J Obstet Gynecol 2008;47(2):141-150]

Addresses: [Chen, Chih-Ping] Mackay Mem Hosp, Dept Obstet & Gynecol, Taipei, Taiwan;

[Chen, Chih-Ping] Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan; [Chen, Chih-Ping] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Chen, Chih-Ping] China Med Univ, Coll Chinese Med, Sch Chinese Med, Taichung, Taiwan; [Chen, Chih-Ping] Natl Yang Ming Univ, Inst Clin &

Community Hlth Nursing, Taipei 112, Taiwan

Reprint Address: Chen, CP, Mackay Mem Hosp, Dept Obstet & Gynecol, 92,Sect 2,Chung Shan N Rd, Taipei, Taiwan.

E-mail Address: cpc_mmh@yahoo.com

Cited References: 1996, FED REG, V61, P8781.

*CDCP, 1991, MMWR-MORBID MORTAL W, V40, P513.

*CDCP, 1992, MMWR-MORBID MORTAL W, V41, P1.

*CDCP, 2004, MMWR-MORBID MORTAL W, V53, P362.

ADAMS MJ, 1995, TERATOLOGY, V51, P311.

(2)

AFMAN LA, 2001, QJM-MON J ASSOC PHYS, V94, P159.

BANHIDYA F, 2008, INT J GYNECOL OBSTET, V100, P86, DOI 10.1016/j.ijgo.2007.05.048.

BARBER RC, 1998, AM J MED GENET, V76, P310.

BAYSTON R, 2007, LANCET, V370, P2004.

BEAUDIN AE, 2007, BIRTH DEFECTS RES C, V81, P183, DOI 10.1002/bdrc.20100.

BERRY RJ, 1999, NEW ENGL J MED, V341, P1485.

BLOM HJ, 2006, NAT REV NEUROSCI, V7, P724, DOI 10.1038/nrn1986.

BOTTO LD, 2000, AM J EPIDEMIOL, V151, P862.

BOWER C, 1989, MED J AUSTRALIA, V150, P613.

BOYLES AL, 2005, AM J MED GENET C C, V135, P9, DOI 10.1002/ajmg.c.30048.

BOYLES AL, 2006, ENVIRON HEALTH PERSP, V114, P1547, DOI 10.1289/ehp.9166.

BRODY LC, 2002, AM J HUM GENET, V71, P1207.

BROUWER I, 2007, AM J CLIN NUTR, V86, P897.

BROWN KS, 2004, HUM GENET, V114, P182, DOI 10.1007/s00439-003-1039-9.

CABRERA RM, 2004, BIRTH DEFECTS RES C, V72, P330.

CASTILLA EE, 2003, AM J MED GENET A A, V123, P123, DOI 10.1002/ajmg.a.20230.

CHANGO A, 2000, BRIT J NUTR, V83, P593.

CHANGO A, 2000, MOL GENET METAB, V70, P310.

CHEN LT, 2004, NUTR REV S 2, V62, S40, DOI 10.1301/nr.2004.jun.S40-S43.

CHRISTENSEN B, 1999, AM J MED GENET, V84, P151.

CORNEL MC, 1989, LANCET, V333, P1386.

CORNEL MC, 1989, LANCET, V334, P1530.

CUCKLE HS, 1989, LANCET, V334, P1281.

CZEIZEL AE, 1989, LANCET, V334, P167.

CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832.

CZEIZEL AE, 1996, JAMA-J AM MED ASSOC, V275, P1635.

DEMARCO P, 2002, J HUM GENET, V47, P319.

DEMARCO P, 2003, EUR J HUM GENET, V11, P245, DOI 10.1038/sj.ejhg.5200946.

DEMARCO P, 2006, J HUM GENET, V51, P98, DOI 10.1007/s10038-005-0329-6.

DEMARCO P, 2006, NEUROGENETICS, V7, P201, DOI 10.1007/s10048-006-0052-2.

DEVILLARREAL LEM, 2001, ARCH MED RES, V32, P277.

DEWALS P, 2003, BIRTH DEFECTS RES A, V67, P919, DOI 10.1002/bdra.10124.

DEWALS P, 2007, NEW ENGL J MED, V357, P135.

DOOLIN MT, 2002, AM J HUM GENET, V71, P1222.

ERICKSON JD, 2002, MMWR-MORBID MORTAL W, V51, P1.

FINNELL RH, 2007, EMERY RIMOINS PRINCI, P2648.

FRIEDMAN G, 1999, J NUTR, V129, P1656.

(3)

GABER KR, 2007, CLIN LAB, V53, P69.

GOS M, 2004, J APPL GENET, V45, P363.

GREENLAND S, 1995, FERTIL STERIL, V64, P936.

GROENEN PMW, 2004, AM J OBSTET GYNECOL, V191, P11, DOI 10.1016/j.ajog.2003.12.032.

GUEANTRODRIGUEZ RM, 2003, NEUROSCI LETT, V344, P189, DOI 10.1016/S0304- 3940(03)00468-3.

HALL JG, 1998, MENT RETARD DEV D R, V4, P269.

HANSEN M, 2002, NEW ENGL J MED, V346, P725.

HEIL SG, 1999, EUR J HUM GENET, V7, P393.

HEIL SG, 2001, MOL GENET METAB, V73, P164.

HIBBARD BM, 1964, J OBSTET GYN BR COMM, V71, P529.

HIBBARD ED, 1965, LANCET, V1, P1254.

HOL FA, 1998, CLIN GENET, V53, P119.

HONEIN MA, 2001, JAMA-J AM MED ASSOC, V285, P2981.

HORIE N, 1995, CELL STRUCT FUNCT, V20, P191.

HUM DW, 1988, J BIOL CHEM, V263, P15946.

JOHNSON WG, 2004, AM J MED GENET A A, V124, P339, DOI 10.1002/ajmg.a.20505.

JOHNSTON RB, 2008, PEDIATR RES, V63, P2.

KALLEN B, 2002, OBSTET GYNECOL, V100, P414.

KALLEN B, 2005, BIRTH DEFECTS RES A, V73, P162, DOI 10.1002/bdra.20107.

KAWAKAMI K, 1999, ANTICANCER RES, V19, P3249.

KAWAKAMI K, 2001, CLIN CANCER RES, V7, P4096.

KIBAR Z, 2007, CLIN GENET, V71, P295, DOI 10.1111/j.1399-0004.2007.00793.x.

KIM YI, 2007, NUTR REV, V65, P504, DOI 10.1301/nr.2007.nov.504-511.

KIRKE PN, 1993, Q J MED, V86, P703.

KURINCZUK JJ, 2004, CURR OPIN OBSTET GYN, V16, P201, DOI 10.1097/01.gco.0000129419.90747.9d.

LANCASTER PAL, 1987, LANCET, V2, P1392.

LAURENCE KM, 1981, BRIT MED J, V282, P1509.

LIM U, 2005, J NUTR, V135, P1989.

LOPEZCAMELO JS, 2005, AM J MED GENET A A, V135, P120, DOI 10.1002/ajmg.a.30651.

LUCOCK M, 2000, MOL GENET METAB, V70, P27.

LUCOCK M, 2001, MOL GENET METAB, V73, P322.

MEDVECZKY E, 2004, PHARMACOEPIDEM DR S, V13, P443, DOI 10.1002/pds.900.

MILLS JL, 1990, LANCET, V336, P103.

MILLS JL, 2004, BIRTH DEFECTS RES A, V70, P844, DOI 10.1002/bdra.20075.

(4)

MILUNSKY A, 1989, JAMA-J AM MED ASSOC, V262, P2847.

MORIN I, 2003, MOL GENET METAB, V79, P197, DOI 10.1016/S1096-7192(03)00086-6.

MORRISON K, 1998, ANN HUM GENET 5, V62, P379.

MULINARE J, 1988, JAMA-J AM MED ASSOC, V260, P3141.

OLEARY VB, 2003, MOL GENET METAB, V79, P129, DOI 10.1016/S1096-7192(03)00075-1.

OLEARY VB, 2005, MOL GENET METAB, V85, P220, DOI 10.1016/j.ymgme.2005.02.003.

OLSON CK, 2005, FERTIL STERIL, V84, P1308, DOI 10.1016/j.fertnstert.2005.03.086.

OU CY, 1996, AM J MED GENET, V63, P610.

PADMANABHAN R, 2006, CONGENIT ANOM, V46, P55, DOI 10.1111/j.1741- 4520.2006.00104.x.

PARLEMCDERMOTT A, 2003, J HUM GENET, V48, P190, DOI 10.1007/s10038-003-0008-4.

PARLEMCDERMOTT A, 2006, EUR J HUM GENET, V14, P768, DOI 10.1038/sj.ejhg.5201603.

PARLEMCDERMOTT A, 2007, AM J MED GENET A A, V143, P1174, DOI 10.1002/ajmg.a.31725.

PEI LJ, 2005, BIRTH DEFECTS RES A, V73, P430, DOI 10.1002/bdra.20130.

PERSAD VL, 2002, CAN MED ASSOC J, V167, P241.

PIETRZYK JJ, 2003, J APPL GENET, V44, P111.

RAMPERSAUD E, 2003, CLIN GENET, V63, P210.

RAY JG, 2002, LANCET, V360, P2047.

RAY JG, 2003, QJM-INT J MED, V96, P289, DOI 10.1093/qjmed/hcg043.

RAY JG, 2007, EPIDEMIOLOGY, V18, P362, DOI 10.1097/01.ede.0000257063.77411.e9.

RAY JG, 2008, QJM, DOI 10.1093/QJMED/HCN031.

RELTON CL, 2004, MOL GENET METAB, V81, P273, DOI 10.1016/j.ymgme.2003.12.010.

RICHTER B, 2001, J HUM GENET, V46, P105.

ROBERT E, 1991, REPROD TOXICOL, V5, P83.

ROTHENBERG SP, 2004, NEW ENGL J MED, V350, P134.

SHAW GM, 1995, EPIDEMIOLOGY, V6, P219.

SHAW GM, 2002, AM J MED GENET, V108, P1.

SMITH AD, 2007, AM J CLIN NUTR, V85, P3.

SMITH AD, 2008, AM J CLIN NUTR, V87, P517.

SMITHELLS RW, 1980, LANCET, V1, P339.

SOLOMONS NW, 2007, NUTR REV, V65, P512, DOI 10.1301/nr.2007.nov.512-515.

STANISLAWSKASACHADYN A, 2008, HUM GENET, V123, P289, DOI 10.1007/s00439-008- 0475-y.

STEGMANN K, 1999, AM J MED GENET, V87, P23.

SUAREZ L, 2003, ANN EPIDEMIOL, V13, P81.

(5)

TORIELLO HV, 2005, GENET MED, V7, P283.

TRINH BN, 2002, HUM GENET, V111, P299, DOI 10.1007/s00439-002-0779-2.

ULRICH CM, 2000, CANCER EPIDEM BIOMAR, V9, P1381.

VANDERLINDEN IJM, 2006, P NUTR SOC, V65, P204, DOI 10.1079/PNS2006495.

VANDERLINDEN IJM, 2007, MOL GENET METAB, V91, P98, DOI 10.1016/j.ymgme.2007.01.009.

VANDERPUT NMJ, 1995, LANCET, V346, P1070.

VANDERPUT NMJ, 1997, QJM-MON J ASSOC PHYS, V90, P111.

VANDERPUT NMJ, 1997, QJM-MON J ASSOC PHYS, V90, P505.

VANDERPUT NMJ, 1997, QJM-MON J ASSOC PHYS, V90, P511.

VANDERPUT NMJ, 1998, AM J HUM GENET, V62, P1044.

VANLOON K, 1992, FERTIL STERIL, V58, P875.

VOLCIK KA, 2003, BIRTH DEFECTS RES A, V67, P154, DOI 10.1002/bdra.10008.

VOLCIK KA, 2003, BIRTH DEFECTS RES A, V67, P924, DOI 10.1002/bdra.10029.

WALD N, 1991, LANCET, V338, P131.

WEISBERG I, 1998, MOL GENET METAB, V64, P169.

WERLER MM, 1993, JAMA-J AM MED ASSOC, V269, P1257.

WHITEHEAD AS, 1995, QJM-INT J MED, V88, P763.

WILDING CS, 2004, BIRTH DEFECTS RES A, V70, P483, DOI 10.1002/bdra.20038.

WILSON A, 1999, MOL GENET METAB, V67, P317.

WOELLER CF, 2007, J BIOL CHEM, V282, P17623, DOI 10.1074/jbc.M702526200.

WU YW, 2006, BIRTH DEFECTS RES A, V76, P718, DOI 10.1002/bdra.20313.

ZHU HP, 2003, MOL GENET METAB, V78, P216, DOI 10.1016/S1096-7192(03)00008-8.

Cited Reference Count: 131 Times Cited: 3

Publisher: ELSEVIER SINGAPORE PTE LTD

Publisher Address: 3 KILLINEY ROAD 08-01, WINSLAND HOUSE 1, SINGAPORE, 239519, SINGAPORE

ISSN: 1028-4559

29-char Source Abbrev.: TAIWAN J OBSTET GYNECOL ISO Source Abbrev.: Taiwan. J. Obstet. Gynecol.

Source Item Page Count: 10

Subject Category: Obstetrics & Gynecology ISI Document Delivery No.: 371GH

參考文獻

相關文件

 Spinal presentations: Spina bifida, myelomeningocele, congenital dermal sinus, lipomatous malformations, split-cord malformations, and caudal agenesis..  Anencephaly:

The aim of this article is to review the management of oral leukoplakia. The topics of interest are clinical diagnosis, methods of management and their outcome, factors associated

The great majority of HPV relate SCC of the OP is nonkeratinizing as described above. However, more re- cently increasing numbers of variants of squamous cell carcinoma,

Accurate identification of the microscopic risk factors of oral and oropharyngeal (OP) squamous cell carcinomas (SCC) and their morphologic variants is of at most importance, as

Clinical findings and risk factors to oral squamous cell carcinoma in young patients: A 12-year retrospective analysis.. Hellen-Bandeira-de-Pontes Santos 1 , Thayana-Karla-Guerra

Additionally, we review the literature for cases of benign glomus tumor in the oral regions and offer data on the clinical and histopathologic features of this rare tumor.. CASE

On the contrary, this case teaches that T1 hyperintensity and T2 hypointensity, when associated with other malig- nancy features in buccal space lesion such as low ADC values

(i) spectral factorization associated with circular cones; (ii) smooth and nonsmooth analysis for f L θ given as in (7); (iii) the so-called L θ -convexity; and (iv) L θ